Publications

Search
Found 13 results
Filters: Author is Soumerai, S.B.  [Clear All Filters]
Journal Article
Soumerai SB, Zhang F, Ross-Degnan D, Ball DE, LeCates RF, Law M., et al. Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health affairs (Project Hope)Health.Aff.(Millwood). 2008;27(3):w185-95.
Soumerai SB, Zhang F, Ross-Degnan D, Ball DE, LeCates RF, Law M., et al. Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Affairs. 2008;27(3):w185-w195.
Law M., Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. The Journal of clinical psychiatryJ.Clin.Psychiatry. 2008;69(1):47-53.
Law M., Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. The Journal of clinical psychiatry. 2008;69(1):47.
Law M., Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: Results of a longitudinal, population-based study. Clinical therapeutics. 2010;32(4):729-741.
Law M., Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clinical therapeuticsClin.Ther.. 2010;32(4):729-41; discussion 716.
Lu CY, Law M., Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of Prior Authorization on the Use and Costs of Lipid-Lowering Medications Among Michigan and Indiana Dual Enrollees in Medicaid and Medicare: Results of a Longitudinal, Population-Based Study. Clinical Therapeutics. 2011;33(1):135-144.
Lu CY, Law M., Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clinical Therapeutics. 2011;33(1):135-144.
Law M., Ross-Degnan D, Soumerai SB. Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements. Psychiatric services (Washington, D.C.)Psychiatr.Serv.. 2008;59(5):540-546.
Law M., Majumdar SR, Soumerai SB. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ (Clinical research ed.)BMJ. 2008;337:a1055.
Law M., Majumdar SR, Soumerai SB. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ: British Medical Journal. 2008;337.
Law M., Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of internal medicine. 2009;169(21):1969.
Law M., Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of Internal MedicineArch.Intern.Med.. 2009;169(21):1969-1974.